HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marion Vermeulen Selected Research

Marion Vermeulen Research Topics

Disease

17Infections
05/2022 - 06/2009
6COVID-19
06/2022 - 01/2021
4Hepatitis B
01/2017 - 06/2009
2Reinfection
03/2021 - 01/2021
2Breakthrough Infections
01/2021 - 04/2020
2Hepatitis C
01/2015 - 01/2013
2Viremia
10/2013 - 06/2009
1Pneumonia (Pneumonitis)
01/2022
1Syphilis
01/2015
1Persistent Infection
07/2013
1Communicable Diseases (Infectious Diseases)
04/2012

Drug/Important Bio-Agent (IBA)

6Hepatitis B Surface Antigens (HBsAg)FDA Link
04/2020 - 06/2009
6N-acetyltalosaminuronic acid (NAT)IBA
01/2019 - 06/2009
6Nucleic AcidsIBA
01/2017 - 06/2012
4VaccinesIBA
03/2021 - 01/2016
3Proteins (Proteins, Gene)FDA Link
03/2021 - 07/2013
3DNA (Deoxyribonucleic Acid)IBA
04/2020 - 06/2009
2AntibodiesIBA
05/2022 - 01/2012
2AntigensIBA
09/2021 - 06/2012
2Immunodominant EpitopesIBA
03/2021 - 01/2021
1Antiviral Agents (Antivirals)IBA
01/2022
1SolutionsIBA
01/2022
1Saline SolutionIBA
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1ABO Blood-Group SystemIBA
09/2021
1Indicators and Reagents (Reagents)IBA
02/2021
1recombinant soluble CD4IBA
07/2013
1Biological ProductsIBA
01/2012
1Biomarkers (Surrogate Marker)IBA
01/2011
1Hepatitis B Core AntigensIBA
06/2009

Therapy/Procedure

4Blood Transfusion (Blood Transfusions)
06/2022 - 06/2009
1Therapeutics
01/2022
1Erythrocyte Transfusion
01/2021